[Angioimmunoblastic lymphadenopathy with dysproteinemia].

Area of Science:

• Hematology
• Immunology
• Oncology

Context:

• Angioimmunoblastic lymphadenopathy with dysproteinemia (AID) presents as a lymphomatous-like disease.
• Characterized by distinct lymph node pathology and significant dysproteinemia.
• Clinical presentation and disease progression in AID are highly variable.

Purpose:

• To describe the key features of Angioimmunoblastic lymphadenopathy with dysproteinemia.
• To highlight the diagnostic challenges and variable clinical course.
• To discuss the current understanding of its nosographic classification.

Summary:

• AID involves lymph node abnormalities and severe dysproteinemia, mimicking lymphoma.
• Patients may experience acquired immunodeficiency, infections, and potential neoplastic development.
• The disease course can range from spontaneous resolution to fatal complications, lacking specific treatments.

Impact:

• Clarifies the multifaceted nature of Angioimmunoblastic lymphadenopathy with dysproteinemia.
• Underscores the need for further research into its classification and management.
• Informs clinicians about the diverse clinical scenarios and potential outcomes associated with AID.